Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04550494
Title Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

ovarian cancer

prostate cancer

breast cancer

stomach cancer

pancreatic cancer

Therapies

Talazoparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
National Cancer Institute Developmental Therapeutics Clinic Recruiting Bethesda Maryland 20892 United States Details
National Institutes of Health Clinical Center Recruiting Bethesda Maryland 20892 United States Details
University of Oklahoma Health Sciences Center Recruiting Oklahoma City Oklahoma 73104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field